acetylcysteine has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schrey, M; van Hagen, D; Winnett, G | 1 |
| Chang, YH; Chen, CW; Lin, WW; Tsi, CJ | 1 |
| Alba, G; Alvarez-Maqueda, M; Bedoya, FJ; Chacón, P; El Bekay, R; Martín-Nieto, J; Monteseirín, J; Pintado, E; Sobrino, F; Vega, A | 1 |
| Fang, NY; Gao, PJ; Guo, SJ; Han, WQ; Shen, WL; Wu, LY; Zhang, J; Zhu, DL | 1 |
| Bienes-Martínez, R; Lucio-Cazana, J; Parra-Cid, T; Ramirez-Rubio, S; Reyes-Martin, P | 1 |
| Carter, AB; Chen, BB; Henderson, FC; Mallampalli, RK; Ryan, AJ; Tephly, LA; Vennalaganti, PR | 1 |
| Clinckspooor, I; Colin, IM; Decallonne, B; Denef, JF; Gérard, AC; Many, MC; Poncin, S | 1 |
| Kim, DH; Kim, EH; Kim, NJ; Na, HK; Song, NY; Suh, YG; Surh, YJ | 1 |
8 other study(ies) available for acetylcysteine and 15-deoxy-delta(12,14)-prostaglandin j2
| Article | Year |
|---|---|
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
Topics: Acetylcysteine; Antioxidants; Aromatase; Aromatase Inhibitors; Breast; Breast Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibroblasts; Glutathione; Humans; Hydrogen Peroxide; Oxidation-Reduction; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Sulfhydryl Reagents; Transcription Factors; Tumor Cells, Cultured | 2003 |
Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Line; DNA-Binding Proteins; Down-Regulation; Enzyme Induction; Glutathione; HT29 Cells; Humans; Interferon Regulatory Factor-1; Interferon-gamma; Interleukin-6; Janus Kinase 2; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxisomes; Phosphoproteins; Phosphorylation; Prostaglandin D2; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 2003 |
15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes.
Topics: Acetylcysteine; Allopurinol; Blotting, Western; Buthionine Sulfoximine; Cells, Cultured; Chromans; Cyclic N-Oxides; Cyclopentanes; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Ions; Lymphocytes; Membrane Proteins; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phenanthrolines; Phosphatidylinositol 3-Kinases; Prostaglandin D2; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Temperature; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Xanthine Oxidase | 2004 |
Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Topics: Acetylcysteine; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Connective Tissue; Dose-Response Relationship, Drug; Fibroblasts; Free Radical Scavengers; Male; NF-kappa B; Oxidative Stress; Pioglitazone; PPAR gamma; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Thiazolidinediones; Time Factors; Transcription Factor AP-1 | 2008 |
15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
Topics: Acetylcysteine; Antioxidants; Buthionine Sulfoximine; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Free Radical Scavengers; Glutathione; Humans; Mesangial Cells; PPAR gamma; Prostaglandin D2; Prostaglandins A; Reactive Oxygen Species; Sulfhydryl Compounds; Up-Regulation | 2008 |
15-deoxy-Delta12,14-prostaglandin J2 impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase.
Topics: Acetylcysteine; Animals; Cell Line; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Epithelial Cells; Free Radical Scavengers; Mice; Oxidative Stress; Phosphatidylcholines; Prostaglandin D2; Reactive Oxygen Species | 2008 |
N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro.
Topics: Acetylcysteine; Animals; Cells, Cultured; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-1alpha; Mice; Mice, Inbred NOD; Peroxiredoxins; Prostaglandin D2; Rats; Reactive Oxygen Species; Recombinant Proteins; Thyroid Gland; Thyroiditis, Autoimmune | 2010 |
Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Topics: Acetylcysteine; Breast Neoplasms; Cell Line, Tumor; Female; Glutamate-Cysteine Ligase; Glutathione; Humans; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Propionates; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Quinolines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2011 |